pubmed-article:7835247 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0001175 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0235032 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C1518296 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0521390 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0072899 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0220839 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0449560 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
pubmed-article:7835247 | lifeskim:mentions | umls-concept:C0449435 | lld:lifeskim |
pubmed-article:7835247 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:7835247 | pubmed:dateCreated | 1995-2-27 | lld:pubmed |
pubmed-article:7835247 | pubmed:abstractText | Human immunodeficiency virus type 1 (HIV) infection of the central nervous system is characterized by neuronal loss in discrete areas of the central nervous system. We have previously demonstrated that HIV-infected monocytes in culture with astroglial cells produce high levels (> or = 200 pg/ml) of the cytokine tumor necrosis factor-alpha (TNF alpha). We now demonstrate that TNF alpha (> or = 200 pg/ml) is neurotoxic to cultured primary human fetal cortical neurons at both light and electron microscopic levels. Subtoxic doses of TNF alpha (50 pg/ml) are neurotoxic in combination with the glutamate (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid (AMPA) subtype receptor agonist AMPA (100 microM). The neurotoxic effects of TNF alpha (200 pg/ml) are blocked in part by the AMPA receptor antagonist, 6-cyano-7-nitroquinoxaline-2, 3-dione (10 microM). This suggests that TNF alpha may exert neurotoxic effects on human neurons by indirect activation of AMPA receptors, which may be important in the pathogenesis and treatment of HIV-mediated encephalopathy. | lld:pubmed |
pubmed-article:7835247 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7835247 | pubmed:language | eng | lld:pubmed |
pubmed-article:7835247 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7835247 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7835247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7835247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7835247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7835247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7835247 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7835247 | pubmed:issn | 0378-5866 | lld:pubmed |
pubmed-article:7835247 | pubmed:author | pubmed-author:del CerroMM | lld:pubmed |
pubmed-article:7835247 | pubmed:author | pubmed-author:GelbardH AHA | lld:pubmed |
pubmed-article:7835247 | pubmed:author | pubmed-author:EpsteinL GLG | lld:pubmed |
pubmed-article:7835247 | pubmed:author | pubmed-author:del CerroCC | lld:pubmed |
pubmed-article:7835247 | pubmed:author | pubmed-author:DiLoretoDD | lld:pubmed |
pubmed-article:7835247 | pubmed:author | pubmed-author:DzenkoK AKA | lld:pubmed |
pubmed-article:7835247 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7835247 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:7835247 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7835247 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7835247 | pubmed:pagination | 417-22 | lld:pubmed |
pubmed-article:7835247 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:meshHeading | pubmed-meshheading:7835247-... | lld:pubmed |
pubmed-article:7835247 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:7835247 | pubmed:articleTitle | Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. | lld:pubmed |
pubmed-article:7835247 | pubmed:affiliation | Department of Neurology, University of Rochester Medical Center, N.Y. 14642. | lld:pubmed |
pubmed-article:7835247 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7835247 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:7835247 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7835247 | lld:pubmed |